Premium
Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?
Author(s) -
Allen F.J.,
Velden D.J.J. Van,
Heyns C.F.
Publication year - 1995
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1995.tb07385.x
Subject(s) - medicine , chromogranin a , stage (stratigraphy) , enolase , immunoperoxidase , oncology , prostate , prostate cancer , adenocarcinoma , carcinoma , pathology , cancer , immunohistochemistry , biology , immunology , paleontology , antibody , monoclonal antibody
Objective To assess whether the presence of neuroendocrine (NE) cells is of value as an independent indicator of poor prognosis in patients with prostate carcinoma. Patients and methods A series of 160 consecutive patients with prostate carcinoma was studied retrospectively. In 120 there was sufficient tissue for review and to perform immunoperoxidase stains for neuron specific enolase (NSE) and chromogranin A (CGA). All patients had a potential follow‐up of at least 5 years. Results Five‐year survival was poorer for patients with a high tumour grade and stage at presentation compared to those with a lower grade and stage. NE cells were more common in higher grade and stage disease, but 5‐year survival did not differ significantly between patients with NE cell positive and negative tumours. Conclusion NE cells are of no practical value as an independent prognostic indicator in patients with pros‐tatic adenocarcinoma.